药学服务的经济学评价方法(4)
[ 4 ] LU TH， LEE YY， TSAI SC， et al. The outcome of clinical pharmacists’interventions in a Taiwanese hospital on pharmacoeconomics and cost saving[J]. J Clin Exp Med，2014，6(4)：139-142.
[ 5 ] KOZMA CM， REEDER CE， SCHULZ RM. Economic，clinical，and humanistic outcomes： a planning model for pharmacoeconomic research[J].Clin Ther，1993，15(6)：1121-1132.
[ 6 ] 孙敏霞. 高血压药物治疗依从性及药师干预效果分析[J]. 中西医结合心血管病电子杂志， 2015(3)：75-76.
, http://www.100md.com
[ 7 ] VO TH， CHARPIAT B， CATOIRE C， et al. Tools for assessing potential significance of pharmacist interventions：a systematic review[J]. Drug Saf，2016，39(2)：1-16.
[ 8 ] TOUCHETTE DR，DOLORESCO F，SUDA KJ，et al. Economic evaluations of clinical pharmacy services：2006- 2010[J]. Pharmacotherapy，2014，34(8)：771-793
[ 9 ] RUBIO-VALERA M， BOSMANS J，FERN?NDEZ A， et al. Correction：cost-effectiveness of a community pharmacist intervention in patients with depression：a randomized controlled trial：PRODEFAR Study[J]. PLoS One，2013，8(8)：e70588.
, http://www.100md.com
[10] 金曉敏，郑亚清，许华.浅谈医院全成本核算[J].医院管理论坛，2010，27(7)：21-22.
[11] WALLERSTEDT SM，BLADH L，AMSBERG J. A cost- effectiveness analysis of an in-hospital clinical pharmacist service[J]. BMJ Open，2012，2(1)：e000329.
[12] SIMPSON SH，LIER DA，MAJUMDAR SR， et al. Cost- effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with type 2 diabetes： results from a randomized controlled trial[J]. Diabet Med，2015，32(7)：899-906.
, http://www.100md.com
[13] GARWOOD CL， CURTIS KD， BELANGER GJ， et al. Preliminary data from a pharmacist-managed anticoagulation clinic embedded in a multidisciplinary patient-centered medical home： a coordinated quality，cost-savings model[J]. J Am Geriatr Soc，2014，62(3)：536-540.
[14] 北京大学中国医药经济研究中心药品不良反应经济成本研究课题组.药品不良反应直接经济成本研究[J].中国药物经济学，2007(2)：30-35.
[15] GALLAGHER J，CARTHY SM，LYNCH D， et al. Cost- outcome description of clinical pharmacist interventions in a university teaching hospital[J]. BMC Health Services Res，2014，14(1)：177.
, 百拇医药
[16] GRAY DR，GARABEDIAN-RUFFALO SM，CHRETIEN SD. Cost-justification of a clinical pharmacist-managed anticoagulation clinic[J]. Ann of Pharmacotherapy，2007，41(3)：496-501.
[17] YOU JHS， CHENG G， CHAN TYK. Comparison of a clinical pharmacist-managed anticoagulation service with routine medical care：impact on clinical outcomes and health care costs[J]. Hong Kong Med J，2008，14(Suppl 3)：S23-S27.
(收稿日期：2017-10-30 修回日期：2017-12-04)
(编辑：孙 冰), http://www.100md.com(庄涛 徐晓媛)
[ 5 ] KOZMA CM， REEDER CE， SCHULZ RM. Economic，clinical，and humanistic outcomes： a planning model for pharmacoeconomic research[J].Clin Ther，1993，15(6)：1121-1132.
[ 6 ] 孙敏霞. 高血压药物治疗依从性及药师干预效果分析[J]. 中西医结合心血管病电子杂志， 2015(3)：75-76.
, http://www.100md.com
[ 7 ] VO TH， CHARPIAT B， CATOIRE C， et al. Tools for assessing potential significance of pharmacist interventions：a systematic review[J]. Drug Saf，2016，39(2)：1-16.
[ 8 ] TOUCHETTE DR，DOLORESCO F，SUDA KJ，et al. Economic evaluations of clinical pharmacy services：2006- 2010[J]. Pharmacotherapy，2014，34(8)：771-793
[ 9 ] RUBIO-VALERA M， BOSMANS J，FERN?NDEZ A， et al. Correction：cost-effectiveness of a community pharmacist intervention in patients with depression：a randomized controlled trial：PRODEFAR Study[J]. PLoS One，2013，8(8)：e70588.
, http://www.100md.com
[10] 金曉敏，郑亚清，许华.浅谈医院全成本核算[J].医院管理论坛，2010，27(7)：21-22.
[11] WALLERSTEDT SM，BLADH L，AMSBERG J. A cost- effectiveness analysis of an in-hospital clinical pharmacist service[J]. BMJ Open，2012，2(1)：e000329.
[12] SIMPSON SH，LIER DA，MAJUMDAR SR， et al. Cost- effectiveness analysis of adding pharmacists to primary care teams to reduce cardiovascular risk in patients with type 2 diabetes： results from a randomized controlled trial[J]. Diabet Med，2015，32(7)：899-906.
, http://www.100md.com
[13] GARWOOD CL， CURTIS KD， BELANGER GJ， et al. Preliminary data from a pharmacist-managed anticoagulation clinic embedded in a multidisciplinary patient-centered medical home： a coordinated quality，cost-savings model[J]. J Am Geriatr Soc，2014，62(3)：536-540.
[14] 北京大学中国医药经济研究中心药品不良反应经济成本研究课题组.药品不良反应直接经济成本研究[J].中国药物经济学，2007(2)：30-35.
[15] GALLAGHER J，CARTHY SM，LYNCH D， et al. Cost- outcome description of clinical pharmacist interventions in a university teaching hospital[J]. BMC Health Services Res，2014，14(1)：177.
, 百拇医药
[16] GRAY DR，GARABEDIAN-RUFFALO SM，CHRETIEN SD. Cost-justification of a clinical pharmacist-managed anticoagulation clinic[J]. Ann of Pharmacotherapy，2007，41(3)：496-501.
[17] YOU JHS， CHENG G， CHAN TYK. Comparison of a clinical pharmacist-managed anticoagulation service with routine medical care：impact on clinical outcomes and health care costs[J]. Hong Kong Med J，2008，14(Suppl 3)：S23-S27.
(收稿日期：2017-10-30 修回日期：2017-12-04)
(编辑：孙 冰), http://www.100md.com(庄涛 徐晓媛)